Benzinga | Aug 3, 2021 05:14PM EDT

CytoSorbents Q2 EPS $(0.11) Misses $(0.04) Estimate, Sales $12.00M Miss $12.27M Estimate

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.04) by 175 percent. This is a 37.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $12.00 million which missed the analyst consensus estimate of $12.27 million by 2.20 percent. This is a 22.51 percent increase over sales of $9.79 million the same period last year.